SCHEMBL18598046

SCHEMBL18598046

CCOC(=O)C(CO)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)C(=O)O

nearest known ligand 0.74

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.74
▸ ACE P12821 14/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890541 1.00 MME (0.74) MMEACE
SCHEMBL14891213 0.90 MME (0.73) MMEACE
SCHEMBL18597991 0.88 MME (0.61) MMEACE
SCHEMBL14891459 0.86 MME (1.00) MMEACE
SCHEMBL18411073 0.85 MME (0.54) MMEACE
SCHEMBL17598748 0.85 MME (0.58) MMEACE
SCHEMBL11969730 0.85 MME (0.54) MMEACE
SCHEMBL11970064 0.85 MME (0.54) MMEACE
SCHEMBL11970092 0.81 MME (0.56) MMEACE
SCHEMBL18597891 0.80 MME (0.56) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-B1 OXALIC ACID AMIDES AS NEPRILYSIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND PREPARATION THEREOF THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-03-08 — — EP disclosed
Send feedback